Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones

Jan 29, 2025

DJ Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 3.52% to $2.19 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.03% to 19,733.59 and the Dow Jones Industrial Average rising 0.31% to 44,850.35.

Inovio Pharmaceuticals Inc. closed 85.15% below its 52-week high of $14.75, which the company reached on April 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.64% to $150.38, Statera Biopharma Inc. (STAB) fell 99.00% to $0.00, and Pfizer Inc. $(PFE)$ fell 0.41% to $26.75.

Trading volume (713,407) remained 415,847 below its 50-day average volume of 1.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled January 28, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

January 28, 2025 17:29 ET (22:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2507522511"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2507522511\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2507522511?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-29 06:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2507522511","market":"hk","top_or_hot":-1,"title":"Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/INO\">$(INO)$</a> slipped 3.52% to $2.19 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 2.03% to 19,733.59 and the Dow Jones Industrial Average  rising 0.31% to 44,850.35. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 85.15% below its 52-week high of $14.75, which the company reached on April 1st. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 1.64% to $150.38, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma Inc</a>. (STAB) fell 99.00% to $0.00, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 0.41% to $26.75. \n</p>\n<p>\n     Trading volume (713,407) remained 415,847 below its 50-day average volume of 1.1 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 28, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 28, 2025 17:29 ET (22:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-01-29 06:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/INO\">$(INO)$</a> slipped 3.52% to $2.19 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 2.03% to 19,733.59 and the Dow Jones Industrial Average  rising 0.31% to 44,850.35. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 85.15% below its 52-week high of $14.75, which the company reached on April 1st. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 1.64% to $150.38, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma Inc</a>. (STAB) fell 99.00% to $0.00, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 0.41% to $26.75. \n</p>\n<p>\n     Trading volume (713,407) remained 415,847 below its 50-day average volume of 1.1 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 28, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 28, 2025 17:29 ET (22:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INO","symbol_name":"伊诺维奥制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2507522511","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2507522511","pubTimestamp":1738103340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slipped 3.52% to $2.19 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 2.03% to 19,733.59 and the Dow Jones Industrial Average  rising 0.31% to 44,850.35.Inovio Pharmaceuticals Inc. closed 85.15% below its 52-week high of $14.75, which the company reached on April 1st.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.64% to $150.38, Statera Biopharma Inc.  fell 99.00% to $0.00, and Pfizer Inc.  fell 0.41% to $26.75.Trading volume  remained 415,847 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled January 28, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswir","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"INO":"伊诺维奥制药"},"translate_title":"与竞争对手相比，Inovio Pharmaceuticals Inc.股票周二表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INO":1},"content_text":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Inovio Pharmaceuticals Inc. $(INO)$ slipped 3.52% to $2.19 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 2.03% to 19,733.59 and the Dow Jones Industrial Average  rising 0.31% to 44,850.35. \n\n\n     Inovio Pharmaceuticals Inc. closed 85.15% below its 52-week high of $14.75, which the company reached on April 1st. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.64% to $150.38, Statera Biopharma Inc. (STAB) fell 99.00% to $0.00, and Pfizer Inc. $(PFE)$ fell 0.41% to $26.75. \n\n\n     Trading volume (713,407) remained 415,847 below its 50-day average volume of 1.1 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled January 28, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 28, 2025 17:29 ET (22:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}